Business Description
Medacta Group SA
ISIN : CH0468525222
Share Class Description:
FRA:6MD: Ordinary SharesTotal Employee Number:
2,165Description
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 1.32 | |||||
Interest Coverage | 16.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.04 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14 | |||||
3-Year EBITDA Growth Rate | 19.3 | |||||
3-Year EPS without NRI Growth Rate | 18.6 | |||||
3-Year FCF Growth Rate | 59 | |||||
3-Year Book Growth Rate | 16.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.14 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.42 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.48 | |||||
9-Day RSI | 48.68 | |||||
14-Day RSI | 49.02 | |||||
3-1 Month Momentum % | -16.57 | |||||
6-1 Month Momentum % | -18.78 | |||||
12-1 Month Momentum % | -5.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.08 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 417.55 | |||||
Days Sales Outstanding | 61.66 | |||||
Days Payable | 73.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.82 | |||||
3-Year Dividend Growth Rate | 10.5 | |||||
Forward Dividend Yield % | 0.82 | |||||
5-Year Yield-on-Cost % | 0.82 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 0.58 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.08 | |||||
Operating Margin % | 16.29 | |||||
Net Margin % | 13.97 | |||||
EBITDA Margin % | 28.75 | |||||
FCF Margin % | 1.4 | |||||
OCF Margin % | 22.32 | |||||
ROE % | 22.74 | |||||
ROA % | 11.16 | |||||
ROIC % | 11.99 | |||||
3-Year ROIIC % | 13.24 | |||||
ROC (Joel Greenblatt) % | 19.91 | |||||
ROCE % | 18.24 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 30.86 | |||||
Forward PE Ratio | 31.47 | |||||
PE Ratio without NRI | 36.12 | |||||
Shiller PE Ratio | 55.52 | |||||
Price-to-Owner-Earnings | 25.03 | |||||
PEG Ratio | 2.36 | |||||
PS Ratio | 4.31 | |||||
PB Ratio | 6.45 | |||||
Price-to-Tangible-Book | 7.36 | |||||
Price-to-Free-Cash-Flow | 307.61 | |||||
Price-to-Operating-Cash-Flow | 19.32 | |||||
EV-to-EBIT | 26.18 | |||||
EV-to-Forward-EBIT | 22.35 | |||||
EV-to-EBITDA | 16.26 | |||||
EV-to-Forward-EBITDA | 14.54 | |||||
EV-to-Revenue | 4.69 | |||||
EV-to-Forward-Revenue | 4.73 | |||||
EV-to-FCF | 334.41 | |||||
Price-to-GF-Value | 0.81 | |||||
Price-to-Projected-FCF | 7.08 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.33 | |||||
Price-to-Graham-Number | 3.41 | |||||
Earnings Yield (Greenblatt) % | 3.81 | |||||
FCF Yield % | 0.33 | |||||
Forward Rate of Return (Yacktman) % | 15.45 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medacta Group SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 683.827 | ||
| EPS (TTM) (€) | 4.78 | ||
| Beta | 0.4388 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 3.8 | ||
| Volatility % | 18.45 | ||
| 14-Day RSI | 49.02 | ||
| 14-Day ATR (€) | 8.375289 | ||
| 20-Day SMA (€) | 145.45 | ||
| 12-1 Month Momentum % | -5.11 | ||
| 52-Week Range (€) | 133 - 191.4 | ||
| Shares Outstanding (Mil) | 19.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medacta Group SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medacta Group SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-09-08 | In 53 days | ||
| CHF 1.100000 Cash Dividend | 2026-05-07 | 154.00 (+6.21%) | ||
| General meeting for 2026 | 2026-05-05 11:00 | 152.00 (+3.40%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-13 15:00 | 167.00 (+1.58%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-13 | 167.00 (+1.58%) | ||
| Annual report for 2025 | 2026-03-12 | 168.00 (+0.36%) | ||
| Guidance call for 2025 | 2026-02-03 15:00 | 178.60 (+4.20%) | ||
| Second quarter earnings results for 2025 | 2025-09-08 | 149.60 (-0.40%) | ||
| General meeting for 2025 | 2025-05-07 | 146.40 (-3.05%) | ||
| Fourth quarter earnings conference call for 2024 | 2025-03-25 13:00 | 78.81 (+0.00%) |
Show
Entries
Medacta Group SA Frequently Asked Questions
What is Medacta Group SA(FRA:6MD)'s stock price today?
The current price of FRA:6MD is €146.00. The 52 week high of FRA:6MD is €191.40 and 52 week low is €133.00.
When is next earnings date of Medacta Group SA(FRA:6MD)?
The next earnings date of Medacta Group SA(FRA:6MD) is 2026-09-08 Est..
Does Medacta Group SA(FRA:6MD) pay dividends? If so, how much?
The Dividend Yield %  of Medacta Group SA(FRA:6MD) is 0.82% (As of Today), Highest Dividend Payout Ratio of Medacta Group SA(FRA:6MD) was 0.22. The lowest was 0.12. And the median was 0.16. The  Forward Dividend Yield % of Medacta Group SA(FRA:6MD) is 0.82%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medacta Group SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers